PetCaseFinder

Peer-reviewed veterinary case report

Cardiac troponin I levels drop after treating immune anemia in dogs

By Cartwright, J A et al.·Published in The Journal of small animal practice·2015·Royal (Dick) School of Veterinary Studies, United Kingdom·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Serum cardiac troponin I concentrations decrease following treatment of primary immune-mediated haemolytic anaemia.

Species:
dog

Plain-English summary

A group of 19 dogs diagnosed with primary immune-mediated hemolytic anemia (a condition where the immune system attacks red blood cells) had their heart health monitored by measuring a protein called cardiac troponin I. Before treatment, these dogs showed elevated levels of this protein, indicating potential heart damage. After receiving treatment for their anemia, the dogs' red blood cell counts improved significantly, and their cardiac troponin I levels decreased, suggesting that their heart health also improved. This finding highlights the importance of treating anemia not just for blood health, but also for overall heart function.

People also search for: dog anemia treatment · elevated cardiac troponin I in dogs · immune-mediated hemolytic anemia in dogs

Abstract

OBJECTIVES: The measurement of serum cardiac troponin I concentrations in dogs with a range of non-primary cardiac illnesses suggests that cardiac myocyte damage is commonplace. Dogs with primary immune-mediated haemolytic anaemia have increased serum cardiac troponin I concentrations at the time of diagnosis. However, it is unclear whether biochemical evidence of cardiac myocyte damage improves following successful treatment of anaemia. METHODS: A haematology profile was performed and serum cardiac troponin I concentrations were measured in 19 dogs with primary immune-mediated haemolytic anaemia before and after treatment. RESULTS: The haematocrit increased significantly (P = 0 &#xb7; 0001) following treatment of primary IMHA (median pre: 0 &#xb7; 13 L/L, median post: 0 &#xb7; 33 L/L). The serum cardiac troponin I concentrations decreased significantly (P < 0 &#xb7; 05) after treatment (median pre: 0 &#xb7; 26 ng/mL, median post: 0 &#xb7; 16 ng/mL). CLINICAL SIGNIFICANCE: Serum cardiac troponin I concentration decreases following successful treatment of primary immune-mediated haemolytic anaemia. The clinical and prognostic significance of serum cardiac troponin I concentrations before and after treatment in dogs with primary immune-mediated haemolytic anaemia merits further investigation.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/26134761/